Literature DB >> 2459363

Effects of dexamethasone and indomethacin on elastase, alpha 1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates.

J S Gerdes1, M C Harris, R A Polin.   

Abstract

Elastase activity and concentrations of alpha 1-proteinase inhibitor, albumin, and fibronectin were measured in bronchoaleolar lavage (BAL) fluid from ventilated lungs in preterm neonates with lung disease before and after treatment with dexamethasone or indomethacin. Treatment with dexamethasone was associated with a significant decrease in BAL elastase activity but no change in fibronectin, albumin, or alpha 1-proteinase inhibitor concentrations. In contrast, treatment with indomethacin was associated with an increase in BAL elastase activity and fibronectin concentration, with no change in albumin or alpha 1-proteinase inhibitor concentrations. Control groups showed no changes in these BAL fluid biochemical markers during a similar time period. These data indicate that treatment with corticosteroids decreases lung inflammation as measured by BAL elastase activity. Corticosteroid treatment may not inhibit the development of pulmonary fibrosis, because fibronectin concentrations in BAL fluid were unaffected. Indomethacin treatment may augment lung inflammation and fibrosis by increasing BAL elastase activity and fibronectin concentration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459363     DOI: 10.1016/s0022-3476(88)80390-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.

Authors:  K Tullus; G W Noack; L G Burman; R Nilsson; B Wretlind; A Brauner
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

Review 2.  Alpha-1 proteinase inhibitor (a1PI) for preventing chronic lung disease in preterm infants.

Authors:  P Shah; A Ohlsson
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 3.  Chronic lung disease of prematurity: are we too cautious with steroids?

Authors:  M Silverman
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

4.  The effects of salbutamol, beclomethasone, and dexamethasone on fibronectin expression by cultured airway smooth muscle cells.

Authors:  I A Shiels; S D Bowler; S M Taylor
Journal:  Inflammation       Date:  1999-08       Impact factor: 4.092

5.  Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome.

Authors:  J Y Wang; T F Yeh; Y C Lin; K Miyamura; U Holmskov; K B Reid
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

6.  Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants.

Authors:  Erik A Jensen; Kevin C Dysart; Marie G Gantz; Benjamin Carper; Rosemary D Higgins; Martin Keszler; Matthew M Laughon; Brenda B Poindexter; Barbara J Stoll; Michele C Walsh; Barbara Schmidt
Journal:  J Pediatr       Date:  2017-02-28       Impact factor: 4.406

7.  Prediction of individual response to postnatal dexamethasone in ventilator dependent preterm infants.

Authors:  C Kuschel; N Evans; A Lam
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

8.  Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.

Authors:  M A Kari; K Heinonen; R S Ikonen; M Koivisto; K O Raivio
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

9.  Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease.

Authors:  S Kotecha; B Chan; N Azam; M Silverman; R J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

10.  Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment.

Authors:  S H Murch; T T MacDonald; C B Wood; K L Costeloe
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.